Quality of life in survivors of childhood brain tumour and the association of children's diseases on quality of their parents life.


Journal

Psycho-oncology
ISSN: 1099-1611
Titre abrégé: Psychooncology
Pays: England
ID NLM: 9214524

Informations de publication

Date de publication:
05 2019
Historique:
received: 28 10 2018
revised: 05 03 2019
accepted: 07 03 2019
pubmed: 16 3 2019
medline: 28 3 2020
entrez: 16 3 2019
Statut: ppublish

Résumé

Evaluation of children's quality of life (QoL) after finished brain tumour treatment and the association of children's diseases on quality of their parents' life. The study group was consisted of 46 children after brain tumour treatment (aged 4, 5, to 29 years old). The control group was composed of 104 students of primary, secondary, and high schools. One hundred fifty (104 + 46) parents were included in the study. Standardised QoL questionnaires (PEDsQL-4.0, WHOQOL-BREF) were used. Survivors' QoL was assessed from patients' and their parents' point of view, also the association of children's diseases on quality of their parents' life was estimated. QoL of children after brain tumour treatment was lower than in the control group according to the children (P < 0.001) and their parents (P < 0.001). The survivors worst rated their ability to social functioning (P < 0.0010) and physical functioning (P < 0.001) in comparison with self-assessment of healthy children. According to their parents, the functioning of children in all zones was worse than in the control group, mostly in social (P < 0.001) and physical sphere (P < 0.001), too. QoL of children with low-grade tumour was comparable with QoL of children with high-grade tumour). QoL of survivors' caregivers in study was higher than QoL of parents of control groups (P = 0.023). The quality of patients' life after brain tumour treatment is lower in comparison with healthy children. QoL of the parents of survivor is higher than the QoL of healthy children parents. The assessment of QoL of children after brain tumour treatment should be an inherent element of health monitoring.

Identifiants

pubmed: 30875709
doi: 10.1002/pon.5061
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1088-1095

Informations de copyright

© 2019 John Wiley & Sons, Ltd.

Auteurs

Katarzyna Musiol (K)

Department of Pediatric Oncology, Hematology and Chemotherapy, Medical University of Silesia, Katowice.

Weronika Bulska (W)

Department of Pediatric Oncology, Hematology and Chemotherapy, Medical University of Silesia, Katowice.

Paulina Brożek (P)

Department of Pediatric Oncology, Hematology and Chemotherapy, Medical University of Silesia, Katowice.

Barbara Oślizło (B)

Department of Pediatric Oncology, Hematology and Chemotherapy, Medical University of Silesia, Katowice.

Stella Ryzak (S)

Department of Pediatric Oncology, Hematology and Chemotherapy, Medical University of Silesia, Katowice.

Justyna Dubiel (J)

Upper Silesia Children's Care Health Centre, Katowice.

Grażyna Sobol-Milejska (G)

Department of Pediatric Oncology, Hematology and Chemotherapy, Medical University of Silesia, Katowice.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH